Back
Genmab AS 10K Form
Sell
33
GNMSF
Genmab AS
Last Price:
220.28
Seasonality Move:
-0.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GNMSF News And Ratings
See the #1 stock for the next 7 days that we like better than GNMSF
GNMSF Financial Statistics
Sales & Book Value
| Annual Sales: | $2.39B |
|---|---|
| Cash Flow: | $212.55M |
| Price / Cash Flow: | 15.38 |
| Annual Sales: | $70.05 |
| Price / Book: | 3.15 |
Profitability
| EPS (TTM): | 12.18700 |
|---|---|
| Net Income (TTM): | $799.51M |
| Gross Margin: | $2.36B |
| Return on Equity: | 17.81% |
| Return on Assets: | 15.53% |
Genmab AS Earnings Forecast
Key Genmab AS Financial Ratios
- The Gross Profit Margin over the past 7 years for GNMSF is 98.63%.
- The Selling, General & Administrative Expenses for GNMSF have been equal to 20.01% of Gross Profit Margin.
- The Research & Development expenses have been 46.32% of Revenue.
- The Interest Expense is 0.62% of Operating Income.
- The Net Earning history of GNMSF is 26.42% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 15 years.
Genmab AS Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GNMSF |
| Website: | genmab.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.03 |
| Quick Ratio: | 5.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.98 |
|---|---|
| Forward P/E Ratio: | 0 |